An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
NCT06759948
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Generalized Myasthenia Gravis (gMG)
Interventions
DRUG:
GC012F injection
Sponsor
Chongbo Zhao
Collaborators
[object Object]